Susquehanna Fundamental Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,566
Closed -$10M 482
2025
Q4
$10M Hold
30,566
0.34% 74
2025
Q3
$8.63M Sell
30,566
-21,389
-41% -$6.2M 0.34% 73
2025
Q2
$14.5M Sell
51,955
-86,961
-63% -$24.6M 0.39% 74
2025
Q1
$43.3M Buy
+138,916
New +$41M 0.6% 13
2024
Q2
Sell
-10,400
Closed -$2.96M 927
2024
Q1
$2.96M Buy
+10,400
New +$3.04M 0.14% 181
2023
Q4
Sell
-6,751
Closed -$1.81M 89
2023
Q3
$1.81M Sell
6,751
-26,447
-80% -$6.6M 0.12% 147
2023
Q2
$7.37M Hold
33,198
0.27% 110
2023
Q1
$8.03M Sell
33,198
-52,302
-61% -$12.8M 0.19% 149
2022
Q4
$22.5M Hold
85,500
0.39% 56
2022
Q3
$19.3M Buy
+85,500
New +$20.7M 0.33% 68
2022
Q1
$12.6M Buy
+52,302
New +$12M 0.25% 90
2021
Q4
Sell
-37,347
Closed -$7.94M 1415
2021
Q3
$7.94M Buy
37,347
+12,299
+49% +$2.83M 0.15% 171
2021
Q2
$6.11M Buy
25,048
+21,998
+721% +$5.41M 0.11% 249
2021
Q1
$759K Sell
3,050
-32,260
-91% -$7.7M 0.01% 993
2020
Q4
$8.12M Buy
35,310
+25,110
+246% +$5.79M 0.15% 182
2020
Q3
$2.59M Sell
10,200
-200
-2% -$49.5K 0.08% 351
2020
Q2
$2.45M Sell
10,400
-11,100
-52% -$2.53M 0.12% 221
2020
Q1
$4.36M Buy
21,500
+1,900
+10% +$415K 0.87% 34
2019
Q4
$4.72M Buy
19,600
+13,400
+216% +$2.95M 0.62% 43
2019
Q3
$1.2M Buy
6,200
+200
+3% +$38.4K 0.15% 173
2019
Q2
$1.11M Buy
6,000
+1,600
+36% +$286K 0.13% 179
2019
Q1
$836K Sell
4,400
-16,319
-79% -$3.12M 0.1% 235
2018
Q4
$4.03M Buy
20,719
+203
+1% +$39.6K 0.71% 38
2018
Q3
$4.25M Buy
20,516
+11,916
+139% +$2.35M 0.72% 32
2018
Q2
$1.59M Sell
8,600
-6,060
-41% -$1.07M 0.24% 138
2018
Q1
$2.5M Buy
+14,660
New +$2.69M 0.3% 121

Other funds holding AMGN

Susquehanna Fundamental Investments's AMGN Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Amgen (AMGN) in Q1 2026, closing a stake of 30,566 shares — an estimated $10M sold.

Susquehanna Fundamental Investments first reported a position in AMGN in Q1 2018 and held it in 26 quarters. The position peaked at $43.3M in Q1 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 30,566 Amgen shares in Q1 2026, an estimated $10M.
  • Susquehanna Fundamental Investments first reported a position in Amgen in Q1 2018 and held it in 26 quarters.
  • Susquehanna Fundamental Investments's Amgen position peaked at $43.3M in Q1 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.